Last $48.31 USD
Change Today +0.39 / 0.81%
Volume 248.9K
As of 8:04 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

hill-rom holdings inc (HRC) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/15 - $49.33
52 Week Low
04/15/14 - $35.45
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HILL-ROM HOLDINGS INC (HRC)

hill-rom holdings inc (HRC) Related Businessweek News

No Related Businessweek News Found

hill-rom holdings inc (HRC) Details

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through three segments: North America, Surgical and Respiratory Care, and International. It provides patient care systems, including various bed systems, as well as mobility solutions; and patient/resident room solutions, which include architectural products and health care furniture. The company also rents and sells non-invasive therapeutic products and surfaces for the prevention and treatment of various acute and chronic medical conditions, including pulmonary, wound, and bariatric conditions; and provides rentals and health care provider asset management services for moveable medical equipment, such as ventilators, defibrillators, intravenous pumps, and patient monitoring equipment. In addition, it offers surgical products, such as surgical tables, lights, and pendants utilized within the operating rooms; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; operating room disposable products, such as scalpels and blades, light handle systems, skin markers, and other disposable products; and therapeutic products that provide bronchial hygiene for acute and home care patients. Further, the company develops and markets various communications technologies and software solutions to enhance patient safety and efficiency at the point of care. It sells and rents its products primarily to acute and extended care facilities through direct sales force and distributors, as well as sells its products to patients in the home. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Batesville, Indiana.

7,000 Employees
Last Reported Date: 02/3/15
Founded in 1969

hill-rom holdings inc (HRC) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $961.9K
Senior Vice President and President of Hill-R...
Total Annual Compensation: $418.4K
Chief Legal Officer, Senior Vice President of...
Total Annual Compensation: $452.2K
Vice President and Treasurer
Total Annual Compensation: $234.1K
Compensation as of Fiscal Year 2014.

hill-rom holdings inc (HRC) Key Developments

Hill-Rom Holdings Eyes Acquisitions

Hill-Rom Holdings, Inc. (NYSE:HRC) has developed a strategy to improve longer-term margins which will include margin accretive acquisitions and additional operational initiatives.

Hill-Rom Holdings, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Dec. 31, 2014; Provides Earnings Guidance for the Second Quarter of Fiscal 2015; Revised Earnings Guidance for Fiscal 2015

Hill-Rom Holdings, Inc. announced unaudited consolidated earnings results for first quarter ended Dec. 31, 2014. For the quarter, the company reported total revenue of $465 million, operating profit of $19.3 million, net income of $12.1 million or $0.21 diluted per share and net cash provided by operating activities of $31 million compared to the total revenue of $393.4 million, operating profit of $21.4 million, net income of $13.2 million or $0.22 diluted per share and net cash provided by operating activities of $42.3 million for the same quarter a year ago. Operating cash flow was, down primarily due to outflows from restructuring and acquisition integration. Capital expenditures increased by $28 million, due primarily to increased investment in its rental fleet. For the second quarter of fiscal 2015, the company expects reported revenue growth of 13% to 15%. This reflects the following assumptions: low to mid-single digit constant currency organic revenue growth and a negative impact from currency of approximately 4%. Second quarter adjusted earnings per diluted share are expected to be $0.57 to $0.60. Fiscal year 2015 adjusted earnings per share are expected to be $2.44 to $2.50; Full-year reported revenue is expected to grow 11% to 12%. The company's guidance for full year adjusted earnings per diluted share is $2.44 to $2.50 compared to $2.42 to $2.48 previously. The company expects cash flow from operations for the full year to be approximately $250 million, unchanged from prior guidance. Compared to its prior range of 11% to 13%, this reflects slightly stronger constant currency revenue growth, driven by North America capital, offset by the negative impact of the stronger dollar. Its forecast is underpinned by the following assumptions: low single-digit constant currency organic revenue growth and a negative currency impact of approximately 4% compared to the 1% to 2% expectations in its prior guidance. More specifically, this outlook reflects the following: low to mid-single digit revenue growth in North America, up from its prior guidance range of low single-digit growth; flat international constant currency revenue; Surgical and Respiratory Care organic constant currency revenue growth in the low single digits; gross margin of approximately 45%, a slight decrease from its prior guidance of 45% to 46%; R&D spending of approximately 4% to 5% of sales; SG&A that is improving as a percentage of sales; a tax rate of approximately 29% to 30% compared to prior guidance of 30% to 31%, which reflects the benefit of the R&D tax credit reinstatement; and approximately 58 million shares outstanding for the year. The company continues to project 2015 operating cash flow to be approximately $250 million. The company anticipates capital expenditures of approximately $140 million, up from its prior guidance of $110 million. This increase is driven primarily by additional investment in its rental fleet to support expected volume increases from recent contract wins.

Hill-Rom Holdings, Inc. Provides Revenue Guidance for the First Quarter Ended December 31, 2014

Hill-Rom Holdings, Inc. provided revenue guidance for the first quarter ended December 31, 2014. For the period, the company expects to report quarterly revenue of approximately $465 million, an increase of approximately 18%, or approximately 21% on a constant currency basis, compared to last year. Excluding Trumpf Medical revenue, reported revenue grew approximately 3%, or 5% on a constant currency basis.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HRC:US $48.31 USD +0.39

HRC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $46.31 USD +0.84
Integra LifeSciences Holdings Corp $61.24 USD +1.23
Invacare Corp $19.71 USD +0.74
STERIS Corp $64.99 USD +0.47
Teleflex Inc $122.91 USD +1.22
View Industry Companies

Industry Analysis


Industry Average

Valuation HRC Industry Range
Price/Earnings 46.9x
Price/Sales 1.6x
Price/Book 3.6x
Price/Cash Flow 45.5x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HILL-ROM HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at